Athersys (ATHX) Momentum Accelerates Higher
Tweet
Share
E-mailGet Alerts ATHX Hot Sheet
Join SI Premium – FREE
The momentum in Athersys, Inc. (Nasdaq: ATHX) is accelerating. Shares are now up 62%, to $4.01, breaking yesterday $3.95 high.
Shares were at just $1 on Friday, before news Monday of a stem cell deal with Pfizer which has propelled the shares into orbit.
Earlier today, an analyst at WBB Securities upgrade the stock to Buy with an aggressive $8 price target.
While some momentum traders are playing the long side here, still others are setting up to short the shares.
Shares were at just $1 on Friday, before news Monday of a stem cell deal with Pfizer which has propelled the shares into orbit.
Earlier today, an analyst at WBB Securities upgrade the stock to Buy with an aggressive $8 price target.
While some momentum traders are playing the long side here, still others are setting up to short the shares.
You May Also Be Interested In
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
